“…It should be noted that the National Cooperative Drug Discovery Group ("Novel Strategies for the Discovery of PlantDerived Anticancer Agents") (Kinghorn et al, 2003;Balunas et al, 2006), the intellectual predecessor of the P01CA125066 program project, overlaps substantially with the Vietnam-Laos ICBG (Kinghorn et al, 2003(Kinghorn et al, , 2009 in both time period (1990)(1991)(1992)(1993)(1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006) and the cell lines employed in cytotoxicity testing. Cell lines tested for viability against plant extracts during the ICBG included human colon cancer (COL-2), human promyelocytic leukemia (HL-60), human telomerase reverse transcriptase-retinal pigment epithelial cells (hTERT-RPE1), human umbilical vein endothelial cells (HUVEC), human cervical carcinoma, formerly believed to be oral carcinoma (KB); human prostate carcinoma (LNCaP), human lung cancer (LU-1), and human breast cancer (MCF-7) (Soejarto et al, 2002;Kinghorn et al, 2003;Gyllenhaal et al, 2012;Zhang et al, 2016).…”